Justin Stebbing

Professor of Cancer Medicine and Oncology, Imperial College London

Justin is Professor of Cancer Medicine and Oncology at Imperial College, and Consultant Oncologist at Imperial College Healthcare NHS Trust.

Justin is a world-renowned cancer specialist, having published over 600 peer-reviewed papers in journals as well as writing regularly for national newspapers and presenting new data on optimal cancer therapies at the major international conferences. His focus at Imperial is on new therapies in cancer, and the systemic management of patients with solid malignancies including a number of new biomarker-based approaches. His laboratory work is concentrated on new druggable target discovery and gene regulation examining the role of non-coding RNAs in stem cells. He has an extensive clinical practice and links this to a wide number of translational research studies and immunotherapy trials including recent biosimilar studies.

He is a Fellow of the Royal College of Physicians, the American Board of Internal Medicine and the Royal College of Pathologists, and sits on the advisory Boards of a number of international cancer committees. He chairs the World Vaccine Congress and the Irish Cancer Society oversight committee and is on the editorial board of a number of world leading general medical and cancer journals such as the Journal of Clinical Oncology and the Lancet Oncology; he was awarded the Silvia Lawler prize in 2015.

Justin has a triple-first class degree (BM BCh), an MA, and a PhD in Medicine from the University of Oxford (Trinity College), and undertook training and a residency programme at The Johns Hopkins Hospital in the United States. Following his work at Imperial, he was appointed senior lecturer in 2007, and a Professor in 2009.